Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $115.94 | 6 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $105.04 | 5 | $0 (2024) |
| STRATA Skin Sciences, Inc. | $10.90 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $82.70 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($82.70) |
| 2023 | $22.34 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($22.34) |
| 2017 | $10.90 | 1 | STRATA Skin Sciences, Inc. ($10.90) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: IMMUNOLOGY | ||||||
| 04/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: IMMUNOLOGY | ||||||
| 01/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: IMMUNOLOGY | ||||||
| 03/16/2017 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: Dermatological Psoriasis and Vitiligo Treatment | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 8,928 | 16,024 | $1.9M | $644,401 |
| 2022 | 19 | 8,972 | 16,766 | $1.9M | $642,438 |
| 2021 | 21 | 9,737 | 18,137 | $2.2M | $751,547 |
| 2020 | 19 | 10,808 | 19,381 | $2.6M | $763,910 |
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 2,609 | 3,686 | $497,610 | $220,512 | 44.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 1,523 | 1,819 | $363,800 | $106,596 | 29.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 1,515 | 2,165 | $324,750 | $71,881 | 22.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 727 | 821 | $172,410 | $60,376 | 35.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 240 | 260 | $148,200 | $58,786 | 39.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 1,113 | 6,029 | $90,435 | $26,156 | 28.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 355 | 355 | $71,000 | $24,755 | 34.9% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 107 | 119 | $63,070 | $11,938 | 18.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 216 | 216 | $30,240 | $10,631 | 35.2% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 40 | 40 | $22,800 | $9,292 | 40.8% |
| 11403 | Removal of noncancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 103 | 106 | $37,100 | $7,477 | 20.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 50 | 64 | $20,480 | $6,883 | 33.6% |
| 12053 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 5.1-7.5 cm | Office | 2023 | 20 | 24 | $15,360 | $5,993 | 39.0% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 22 | 22 | $12,320 | $5,127 | 41.6% |
| 11643 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm | Office | 2023 | 40 | 40 | $24,000 | $4,652 | 19.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 110 | 118 | $7,670 | $3,730 | 48.6% |
| 11623 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | Office | 2023 | 36 | 36 | $20,160 | $3,706 | 18.4% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 24 | 26 | $6,500 | $1,886 | 29.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 48 | 48 | $3,840 | $1,728 | 45.0% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 13 | $6,045 | $1,216 | 20.1% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 17 | 17 | $4,250 | $1,080 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 2,714 | 3,764 | $508,140 | $226,687 | 44.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 1,326 | 1,536 | $307,200 | $92,532 | 30.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 1,532 | 2,218 | $332,700 | $76,454 | 23.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 661 | 738 | $154,980 | $54,584 | 35.2% |
About Dr. Anthony Perri, MD
Dr. Anthony Perri, MD is a Dermatology healthcare provider based in Conroe, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1003010687.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Perri, MD has received a total of $115.94 in payments from pharmaceutical and medical device companies, with $82.70 received in 2024. These payments were reported across 6 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($115.94).
As a Medicare-enrolled provider, Perri has provided services to 38,445 Medicare beneficiaries, totaling 70,308 services with total Medicare billing of $2.8M. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Conroe, TX
- Active Since 06/14/2007
- Last Updated 09/01/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003010687
Products in Payments
- SPEVIGO (Drug) $105.04
- XTRAC (Device) $10.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Conroe
Dr. Bobbak Mansouri, M.d, M.D
Dermatology — Payments: $15,888
Anita Arora Gill, M.d, M.D
Dermatology — Payments: $14,432
Kristin Wolf, M.d, M.D
Dermatology — Payments: $13,667
Kemunto Mokaya, M.d, M.D
Dermatology — Payments: $9,732
Greg Krenek, M.d, M.D
Dermatology — Payments: $4,466
Jessica Sung Ku, Md, MD
Dermatology